Of (device) taxes, brains & spite

Another Tax Day has come. This year brings a bitter reminder of the perils of U.S. tax policy, particularly the ill-conceived medical device tax. The tax has gobbled an estimated $450 million from manufacturers’ pockets since Jan. 1. While costs could hit $2 billion annually, the true costs in terms of foregone opportunity in medical advances could be incalculable. In an opinion piece in the Wall Street Journal, Siemens Healthcare CEO Gregory Sorenson makes an impassioned appeal on behalf of current and future patients for the repeal of the tax.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.